Physician

Anthony Vu Nguyen, MD

According to 2025 Medicare claims, Anthony Nguyen, MD (NPI: 1831317551) practices hematology/oncology in the Las Vegas-Henderson-North Las Vegas, NV market, with the plurality of this provider's patient population coming from Clark, NV. This provider's primary affiliated billing organization is ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (NPI: 1598770471; TIN: 88-0350180) and primary practice location at 89074-8195. Nguyen is affiliated with the PSW ACO (ACO ID: A5323), participating under the MSSP model.

Nguyen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 683 traditional Medicare patients, billed 194,764 HCPCS/CPT codes, and received $3,490,430 in Medicare payments. The top billing code was 82728 (Ferritin (blood protein) level). Part D data shows 1,202 prescription claims across 190 beneficiaries totaling $3,644,582 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 68 claims. Open Payments data shows 66 records totaling $128,544. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,193,232 to $3,644,582. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,410 to $1,156.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	786	283,139	$2,809,788
2016	831	335,006	$3,732,637
2017	811	372,320	$3,825,350
2018	792	324,158	$3,238,223
2019	844	322,567	$3,386,508
2020	812	332,121	$3,659,997
2021	806	263,064	$3,177,040
2022	750	254,306	$3,281,714
2023	736	241,422	$4,066,610
2024	683	194,764	$3,490,430

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	165	1,095	$1,193,232
2016	186	1,257	$1,306,088
2017	206	1,424	$2,190,395
2018	193	1,390	$2,370,167
2019	201	1,473	$2,587,922
2020	216	1,775	$3,220,704
2021	199	1,595	$4,364,504
2022	202	1,532	$4,701,485
2023	197	1,241	$3,692,192
2024	190	1,202	$3,644,582

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	169	$56,392
2016	N/R	167	$28,989
2017	N/R	64	$12,608
2018	N/R	86	$11,963
2019	N/R	71	$8,682
2020	N/R	42	$3,306
2021	N/R	77	$7,241
2022	24	140	$4,655
2023	N/R	116	$11,492
2024	N/R	68	$1,305

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
82728	Ferritin (blood protein) level	426	1,034	$13
80053	Blood test, comprehensive group of blood chemicals	491	1,547	$10
36415	Insertion of needle into vein for collection of blood sample	512	1,835	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	510	1,864	$8
83540	Iron level	426	1,034	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	77	2,310	$1,119,071
Ibrance	Palbociclib	28	784	$441,998
Promacta	Eltrombopag Olamine	25	750	$370,454
Revlimid	Lenalidomide	18	504	$328,176
Lenalidomide	Lenalidomide	17	476	$252,386

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	32	$778
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	24	$301
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$45,116	BeiGene USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	19	$83,427	BeiGene, Ltd.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anthony Vu Nguyen, MD?

Tedicare shows public-source Medicare data for Anthony Vu Nguyen, MD (NPI 1831317551), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony Vu Nguyen, MD have ACO affiliation data?

Anthony Vu Nguyen, MD is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Anthony Vu Nguyen, MD?

Anthony Vu Nguyen, MD is linked to ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (billing NPI 1598770471) in the available physician profile data.

Does Anthony Vu Nguyen, MD have Open Payments data?

Anthony Vu Nguyen, MD has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.